About
Yanbin Dong serves as Director and Professor at Augusta University's Medical College of Georgia, holding joint appointments across the Department of Pediatrics, Department of Medicine, Georgia Prevention Institute, and Department of Population Health Science. His research bridges molecular biology and population health with emphasis on health disparities in African American communities.
Education:
- Ph.D. in Molecular Biology, Peking University (1995)
- MS in Pathology Residency Program, China Medical College (1988)
- MD in Medicine, Jinzhou Medical College (1985)
Dr. Dong's research program centers on epigenetic mechanisms underlying cardiovascular disease and obesity, particularly examining how dietary factors, sodium intake, and vitamin D influence physiological responses in high-risk populations. His work integrates genomic profiling with clinical interventions to address health inequities, featuring strong focus on translational applications for hypertension management and obesity prevention in youth.
His 2018 publications reveal consistent methodology using epigenome-wide association studies (EWAS) applied to African American cohorts, with thematic emphasis on gene-environment interactions. Key patterns include investigation of mental stress responses, dietary fiber impacts, and sodium reduction trials—all leveraging advanced techniques like miRNA profiling to identify biomarkers for cardiovascular risk stratification.
Scientific Recognition:
- Nominated for American Diabetes Association Diabetes Accelerator Award (2013)
- Outstanding Contributions to Georgia Prevention Institute's 30-Year Success (2012)
Dr. Dong maintains extensive service commitments including departmental leadership since 2015, college-level committees since 2004, and university-wide initiatives through 2016. As an active grant reviewer since 2006, he contributes to research evaluation while leading public health initiatives focused on prevention science since 2013, though specific grant awards aren't detailed in source materials.
He directs research activities through the Georgia Prevention Institute and Center for Biotechnology and Genomic Medicine, where interdisciplinary teams investigate population health determinants using genomic, clinical, and epidemiological approaches to combat cardiovascular disparities.
